Diagnostic system analyzing retinal biomarkers and vascular damage from fundus photographs to assess risk of cardiovascular events. Evaluates stroke and ischemic heart disease risk through automated retinal image analysis in patients with vascular disease. Supports preventive cardiology and risk str...
Manufactured by
Aireen a.s.
Czech Republic
Aireen is a Prague-based medical technology company developing artificial intelligence-powered software as a medical device that enables rapid, non-invasive screening of chronic diseases from digital retinal images. The company's mission is to make early detection of major conditions more accessible and scalable by automating diagnostic analysis that would traditionally require specialist expertise, thereby improving screening compliance and reducing delays in diagnosis. Aireen's solutions are designed to be intuitive and usable by a broad range of healthcare providers, supporting large-scale screening programmes and enhancing patient access to preventive care worldwide.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Optain Health
Australia · 1 relevant product
Mediwhale Inc.
South Korea · 2 relevant products
CHECK-EYE
Germany · 2 relevant products
31 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →10 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 49 closest product alternatives
Optain Health · Australia
AI-powered platform that analyzes retinal images to identify early signs of eye diseases and assess cardiovascular disease risk. The system provides standardized risk assessment reporting to support clinical decision-making and reduce missed diagnoses.
Mediwhale Inc. · South Korea
Deep learning-based platform that processes retinal images to assess cardiovascular, kidney, and eye disease risks. Trained on over 2.1 million clinical data points across diverse populations and imaging devices for robust, generalizable diagnostic performance.
CHECK-EYE · Germany
AI-powered platform for early detection of retinal changes and diabetic retinopathy. Analyzes fundus photographs to identify pathological changes at early stages before symptom onset. Results are generated within minutes and reviewed by medical professionals.
46 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products